** Shares of drug developer ADYX.O slump as much as ~41%
to touch a record low of $3.53
** Co says it received notification from The Nasdaq Stock
Market affirming the delisting of the company's shares due to
noncompliance with initial listing rules urn:newsml:reuters.com:*:nGNX6pJ8cv
** Adynxx has 15 days to decide whether to appeal the
delisting determination and is considering an appeal, co says
** Including Wednesday's losses, ADYX had slumped 40% this
year
(Reporting by Manojna Maddipatla in Bengaluru)
((Reuters Messaging:
manojna.kalyani.thomsonreuters.com@reuters.net))